Perioperative safety and feasibility outcomes of stage IIIA-N2 non-small cell lung cancer following neoadjuvant immunotherapy or neoadjuvant chemotherapy: a retrospective study

BACKGROUND: We sought to determine the perioperative safety and feasibility outcomes of stage IIIA (N2) non-small cell lung cancer (NSCLC) following neoadjuvant immunotherapy or neoadjuvant chemotherapy. METHODS: The clinical details of patients who attended the Affiliated Hospital of Qingdao Univer...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Huang, Zhangfeng, Wu, Zhe, Qin, Yi, Zhao, Yandong, Xuan, Yunpeng, Qiu, Tong, Liu, Ao, Dong, Yanting, Su, Wenhao, Du, Wenxing, Yun, Tianxiang, Wang, Lingjie, Liu, Dahai, Sun, Lili, Jiao, Wenjie
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106052/
https://ncbi.nlm.nih.gov/pubmed/33987383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-1141
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares